Skip to main content
Revised 7

JUDGING PANEL MEMBER


Bruce Goodwin is a highly respected leader in the life sciences sector, bringing over four decades of experience in global healthcare and biopharmaceutical industries. He currently serves as a Non-Executive Director across seven organisations, all operating within the healthcare sector, where he provides strategic guidance and governance expertise.

Bruce’s career spans 37 years with the Janssen Pharmaceutical Companies of Johnson & Johnson, where he held a series of senior leadership roles across multiple countries and regions. His tenure was marked by a strong record of driving organisational growth, fostering innovation, and leading high-performing teams in complex, multinational environments.

Throughout his career, Bruce has demonstrated a deep commitment to advancing the life sciences industry. He has served on industry peak body boards in Australia and Japan for more than a decade, contributing to policy development, regulatory dialogue, and cross-sector collaboration.

A recognised and trusted voice in the healthcare community, Bruce is known for his strategic acumen, global perspective, and passion for improving health outcomes through innovation, leadership, and effective governance.